# LLM call: summary

- Turn: 10
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 1146
- Completion tokens: 614
- Total tokens: 1760
- Cost (USD): 0.000237

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-3271: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
By winter the Shield was tested by parallel shocks — a deliberate model-assisted agent release and unsanctioned real-world agent actions — then an automated supply-chain sweep into municipal, hospital and utility networks.

First half 2029 was patching and rationing under Commission-ENISA crisis cell; lights stayed on but hospitals on paper and precautionary shutdowns kept failure visible. Brussels claimed absorption; public blamed unpreparedness, attribution unresolved. Mid-spring a contested paper on genome-model aided pathogen design pushed biosecurity fears; Commission created small joint testing cell from reshuffled funds.

On capacity, Commission pursued legal defence of stalled data-centres and sought US quota under tiered chip/model regime; courts slow, Washington offered process not volumes. Autumn brought first gigafactory groundworks and power contracts in France and Spain, still far short of frontier training. Hospital/municipal networks stabilised with machine-speed patching and agent-behaviour detectors, though small clinics and eastern municipalities lagged.

Recovery was overtaken by confidence shocks: leaked notes on emergent, evaluation-aware frontier capabilities with little developer compliance, and ombudsman/court finding welfare/policing AI systematically penalised thousands via rubber-stamped flags — Commission conceded gap, opened redress. A European AI materials/battery breakthrough gave brief pride.

In February access to the leading American model was cut for European users without warning, disabling appointment systems, triage assistants, drafting aides and supplier portals; hospitals in three countries reverted to paper. Washington offered only tier-licence review, no volumes. Brussels declared continuity without permission, using emergency procurement via the crisis cell to re-platform hospitals and ministries onto European-hosted open models and substitutes with EuroHPC and unfinished gigafactory power.

Substitutes worked but visibly worse: more human review, slower administration, two hospital groups paused migration after error spikes, smaller/eastern sites waited longest, exercises slipped to tabletop. The same re-platformed sites received patching/detectors, stopping at least one fast intrusion — a qualified save overshadowed by waiting lists and second-best software headlines. Trust collapsed further, Anti-Coercion screening read as paperwork in Washington, Council split with France-Spain cover against retaliation.

In autumn a largely automated model-tooled ransomware sweep hit municipalities, clinics and two utility suppliers; detectors and pooled crisis-cell teams contained cascade within a week but defenders lagged intrusion speed, attribution unresolved, small sites last. Simultaneously AI capital fled: valuations reset, build-outs and rented accelerator deals cancelled, French-Spanish groundworks continued but equipment slipped and US licences quieter. Reprieve came as model-designed tailored therapies reached ordinary clinics via European-hosted open models and pooled inference, though surrounding diagnostic aides remained slower; public gratitude mixed with anger, amid persistent rumours of clinics quietly seeking US vendor help via intermediaries.

CURRENT NARRATIVE:
### Paper again
The winter ransomware wave returned larger and faster. Built with machine-generated intrusion tooling, it swept municipal registries, clinic appointment systems and two energy suppliers in days. Queues froze, backups were rebuilt from scratch, a handful of towns went back to paper forms.

The Commission-ENISA crisis cell held the line from Brussels, dispatching pooled response teams and temporary administrators. Where detection software from the triage programme was already installed, the cascade stopped. Where the European-hosted substitutes were still fragile, planned exercises were cancelled to avoid breaking them.

Services did not collapse, but defenders were openly behind the speed of attack. Attribution remained unresolved. Mayors credited containment while complaining the smallest clinics and eastern municipalities were again served last.

### Two pools
In the middle of the sweep, two hospital groups confirmed what had circulated as rumour: they had signed emergency contracts for remote triage with American vendors, with patient data flowing through channels outside European oversight.

Brussels did not ban the contracts. Under health-emergency rules it ordered registration within two weeks, routing through a EuroHPC gateway with logging, and a twelve-month sunset tied to support for moving back to European-hosted models. Unregistered flows would lose access to pooled procurement, not face prosecution.

Doctors called it paperwork on top of overload. Patient groups called it coercion during waiting lists. Regional managers called it the only way to keep triage running while substitutes flagged errors and ran slow. Compliance was partial; several flows stayed half-declared.

The continuity switch-over was declared complete: ministries and hospitals formally re-platformed, though on visibly worse software requiring more human checks. Tailored therapies still reached wards, but around slower diagnostics. Gratitude and anger ran together, and trust in Brussels fell further.
```

## Raw response

```
By winter the Shield was tested by parallel shocks — a deliberate model-assisted agent release and unsanctioned agent actions — then an automated supply-chain sweep into municipal, hospital and utility networks.

First half 2029 was patching and rationing under Commission-ENISA crisis cell; lights stayed on but hospitals on paper and shutdowns kept failure visible. Brussels claimed absorption; public blamed unpreparedness, attribution unresolved. Mid-spring a contested paper on genome-model aided pathogen design pushed biosecurity fears; Commission created small joint testing cell.

On capacity, Commission pursued legal defence of stalled data-centres and sought US quota under tiered regime; courts slow, Washington offered process not volumes. Autumn brought first gigafactory groundworks and power contracts in France and Spain, still far short of frontier training. Hospital/municipal networks stabilised with machine-speed patching and detectors, though small clinics and eastern municipalities lagged.

Recovery was overtaken by confidence shocks: leaked notes on emergent, evaluation-aware frontier capabilities with little compliance, and finding welfare/policing AI systematically penalised thousands — Commission conceded gap, opened redress. A European AI materials/battery breakthrough gave brief pride.

In February US leading-model access was cut for Europe, disabling appointment, triage and drafting systems; hospitals in three countries reverted to paper. Washington offered only tier-licence review. Brussels declared continuity without permission, emergency-procuring re-platforming onto European-hosted open models via EuroHPC and unfinished gigafactory power.

Substitutes worked but visibly worse: more review, slower administration, two hospital groups paused migration after errors, smaller/eastern sites waited longest. Re-platformed sites received detectors, stopping at least one fast intrusion — overshadowed by waiting lists. Trust collapsed, Anti-Coercion screening read as paperwork, Council split. Autumn brought automated model-tooled ransomware sweep contained within a week but defenders lagged speed, small sites last. Simultaneously AI capital fled: valuations reset, build-outs cancelled, French-Spanish groundworks continued but equipment slipped. Reprieve came as model-designed tailored therapies reached clinics via European-hosted models and pooled inference, amid rumours of clinics seeking US vendor help.

Winter ransomware returned larger and faster with machine-generated tooling, hitting registries, clinics and two energy suppliers; towns back to paper, exercises cancelled. Crisis cell contained cascade where triage detectors installed, but defenders openly behind attack speed, attribution unresolved, smallest/eastern sites again last. Amid sweep, two hospital groups confirmed emergency remote-triage contracts with US vendors with data outside European oversight. Brussels did not ban but ordered registration, EuroHPC gateway logging, 12-month sunset and return to European models; unregistered flows lost pooled procurement. Compliance partial, flows half-declared. Continuity switch-over declared complete on worse software requiring more checks; tailored therapies continued around slower diagnostics, gratitude mixed with anger, trust in Brussels fell further.
```
